Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitrs in Lung Cancer: Case Report and Literature Review

Immune checkpoint inhibitors (ICIs), including antibodies targeting programmed cell death protein-1 (PD-1) and programmed cell death ligand-1 (PD-L1), are being extensively used on advanced human malignancies therapy. The treatment with ICIs have acquired durable tumor inhibition and changed the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Wang, Hu, NaNa, Cao, LeJie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695900/
https://www.ncbi.nlm.nih.gov/pubmed/34956221
http://dx.doi.org/10.3389/fimmu.2021.790051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695900/
https://www.ncbi.nlm.nih.gov/pubmed/34956221
http://dx.doi.org/10.3389/fimmu.2021.790051

Ejemplares similares